SUNEKOS referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
Sunekos Cell 15
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.
Principales ventajas de Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Indicaciones y uso profesional
Indicaciones principales
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Uso profesional
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
Zonas de tratamiento
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
Perfil del paciente
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
Cómo funciona Sunekos Cell 15
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Por qué comprar en Allpara
Allpara ofrece productos SUNEKOS originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.
Preguntas frecuentes
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.
Más productos de Professional Dietetics
Alternativas para la clínica
Retome donde lo dejó
Sunekos Cell 15
Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.
Principales ventajas de Sunekos Cell 15
- CE-marked Class III medical device
- Promotes optimisation of extracellular matrix protein turnover
- Supports neo-collagenesis rather than collagenase
- Helps improve microcirculation
- Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
- Helps regulate physiological pH
- Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
- Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
Indicaciones y uso profesional
Indicaciones principales
- Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
- Cellulite stages I and II
- Cellulite stages III and IV
- Fibrosis and extracellular matrix inflammation associated with cellulite
- Impaired microcirculation associated with cellulite
Uso profesional
Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.
Zonas de tratamiento
- Cellulite-affected areas of the thighs and gluteal/trochanteric region
Perfil del paciente
Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.
Cómo funciona Sunekos Cell 15
Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.
Por qué comprar en Allpara
Allpara ofrece productos SUNEKOS originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.
Preguntas frecuentes
Which cellulite stages does Sunekos Cell 15 treat?
Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.
How does Sunekos Cell 15 differ from lipolytic cellulite treatments?
Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.
Why does Sunekos Cell 15 include an alkaline solution?
The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.